Effect of different compatibilities of effective fraction of Xie-Xin decoction on NF-κB and IκB expression of lung injury rats induced by LPS

Chinese Pharmacological Bulletin

Volumn 23, Issue 11, 2007, Pages 1441-1443

  Yang, Na ^a   Meng, Xian Li ^a   Xiong, Yu Xia ^a  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

I B; Lipopolysaccharide; Lung injury; NF B; Xie Xin decoction

Indexed keywords

ANTHRAQUINONE; DEXAMETHASONE; FLAVONE DERIVATIVE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LUNG INJURY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT;

EID: 38349133729     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Baeuerle P A, Baltimore D. IκB: a specific inhibitor of NF-κB transcription factor [J]. Science, 1988, 242:540-6.
2. Li L B. The effect of Ambroxol and Dexamethasone to inflammatory signal transduction in Lipopolysaccharide-induced acute lung injury in rats [D]. Dissertation of Doctor Degree of Zhejiang University. Zhejiang University, 2005.
3. Xiong Y X, Meng X L, Zhang Y, He Y M. The screening of effective fraction of xie - xin decoction on anti-lipopolysaccharide [J]. Sichuan J Physiol Sci, 2005, 27(3):47.
4. Lo Y C, Lin Y L, Yu K L, et al. San-Huang-Xie-Xin-Tang attenuates inflammatory responses in lipopolysaccharide-exposed rat lungs [J]. J Ethnopharmacol, 2005, 101(5):68-74.
5. Ma Y M, Yan J C, Wang T M, et al. Anti-inflammatory effects of Xiexin decoction on animal models of acute inflammation [J]. Chin Pharmacol Bull, 2006, 22(11):1393-8.
6. Derykere F, Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues [J]. Biotechniques, 1994, 16:405.
7. Bauss F, Dröge W, Männel D N. Tumor necrosis factor mediates endotoxic effects in mice [J]. Infect Immun, 1987, 55(7):1622-5.
8. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities [J]. Lab Invest, 1987, 56(3):234-48.
9. Rahman I, Nee W M. Role of transcription factors in inflammatory lung disease [J]. Thorax, 1998, 53:601-12.
10. Blackwell T S, Blackwell T R, Holden E P, et al. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation [J]. J Immunol, 1996, 157:1630-7.